Effect of GRP119 Receptor Agonist, Compound MBX-2982, on Activity of Human Glucokinase
- Autores: Spasov A.1, Kosolapov V.1, Babkov D.1, Maika O.1
-
Afiliações:
- Volgograd State Medical University, Ministry of Health of the Russian Federation
- Edição: Volume 163, Nº 5 (2017)
- Páginas: 695-698
- Seção: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239198
- DOI: https://doi.org/10.1007/s10517-017-3881-0
- ID: 239198
Citar
Resumo
Validation of the method for studies of glucokinase activators by the spectrophotometric method in an in vitro test system is carried out. The advantage of NAD coenzyme vs. thio-NAD is proven. Manifest activation of glucokinase by MBX-2982 compound (GPR119 agonist) in a wide range of concentrations is demonstrated experimentally.
Sobre autores
A. Spasov
Volgograd State Medical University, Ministry of Health of the Russian Federation
Autor responsável pela correspondência
Email: aspasov@mail.ru
Rússia, Volgograd
V. Kosolapov
Volgograd State Medical University, Ministry of Health of the Russian Federation
Email: aspasov@mail.ru
Rússia, Volgograd
D. Babkov
Volgograd State Medical University, Ministry of Health of the Russian Federation
Email: aspasov@mail.ru
Rússia, Volgograd
O. Maika
Volgograd State Medical University, Ministry of Health of the Russian Federation
Email: aspasov@mail.ru
Rússia, Volgograd